HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.

AbstractBACKGROUND:
Early recurrence of massive proteinuria after renal transplantation occurs in 20% to 30% of patients with steroid-resistant idiopathic nephrotic syndrome and is responsible for graft failure in approximately half of cases. We report our experience with the use of intravenous (IV) cyclosporine (CsA) in children with recurrent proteinuria after renal transplantation.
METHODS:
Between March 1991 and August 2001, 36 renal transplantations were performed in 35 patients with steroid-resistant idiopathic nephrotic syndrome in our institution. Recurrence, defined by proteinuria higher than 50 mg/kg per day in the absence of acute rejection or urinary tract infection, was observed in 17 grafts performed in 16 patients. In patients with recurrence, CsA was administered IV, at an initial dose of 3 mg/kg per day, which was afterward adapted to maintain whole-blood levels between 250 and 350 ng/mL.
RESULTS:
In 14 of 17 cases (82%) with recurrence, proteinuria completely disappeared after 20.8+/-8.4 (range 12-40) days. The treatment was ineffective in the remaining three patients with persistent proteinuria at the end of the second month posttransplantation. Plasma exchanges were performed in four patients during the first 2 months, and proteinuria regressed in three cases and persisted in one. Persistent remission was observed in 11 patients with a follow-up of 3.7+/-3 (range 0.3-9) years. Actuarial graft survival was 92% and 70% at 1 and 5 years.
CONCLUSION:
IV CsA is a safe and effective treatment in children with recurrent nephrotic syndrome after renal transplantation.
AuthorsRémi Salomon, Marie-France Gagnadoux, Patrick Niaudet
JournalTransplantation (Transplantation) Vol. 75 Issue 6 Pg. 810-4 (Mar 27 2003) ISSN: 0041-1337 [Print] United States
PMID12660507 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cyclosporine
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Cyclosporine (administration & dosage)
  • Follow-Up Studies
  • Graft Rejection (drug therapy)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Injections, Intravenous
  • Kidney Failure, Chronic (pathology, surgery)
  • Kidney Transplantation
  • Nephrotic Syndrome (drug therapy, pathology)
  • Postoperative Complications (drug therapy, pathology)
  • Prospective Studies
  • Proteinuria (drug therapy, pathology)
  • Recurrence
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: